HighGravityDataSigned in · PRO
Guidance history, every release
Raised · a change from the previous releaseSame · restated unchanged— · not stated in that releaseEvery value links to its sentence in the filing
| Metric | Oct 31, 2024 FY24 Q3 | Feb 13, 2025 FY24 Q4 | May 1, 2025 FY25 Q1 | Jul 31, 2025 FY25 Q2 | Oct 30, 2025 FY25 Q3 | Feb 12, 2026 FY25 Q4 | Apr 28, 2026 FY26 Q1 | Jul 30, 2026 FY26 Q2 |
|---|---|---|---|---|---|---|---|---|
| For FY2026 | ||||||||
| Currency (Revenue Growth assumption) | — | — | — | — | — | New“+1%” | — | — |
| M&A (Revenue Growth assumption) | — | — | — | — | — | New“+1.5%” | — | — |
| Organic growth (Revenue Growth assumption) | — | — | — | — | — | New“flat to 2%” | — | — |
| Revenue growth | — | — | — | — | — | New“2.5% to 4.5%” | — | — |
| Revenue Growth | — | — | — | — | — | — | New“2.5% to 4.5%” | Raised“4.5% to 6.5%” |
| Adjusted EBITDA | — | — | — | — | — | New“$2,130 to $2,190 million” | Reiterated“$2,130M - $2,190M” | Reiterated“$2,130M - $2,190M” |
| Adjusted EPS | — | — | — | — | — | — | New“$3.45 to $3.57” | Reiterated“$3.45 to $3.57” |
| Adjusted EPS | — | — | — | — | — | New“$3.45 to $3.57” | — | — |
| Adjusted EPS growth at midpoint | — | — | — | — | — | New“+5% growth at the midpoint” | Reiterated“+5% growth at the midpoint” | — |
| Free Cash Flow to Adj. Net Income conversion | — | — | — | — | — | New“~95%” | Reiterated“~95%” | Reiterated“~95%” |
| Adj. tax rate | — | — | — | — | — | New“~23%” | Reiterated“~23%” | — |
| Adjusted tax rate | — | — | — | — | — | — | — | New“~22%” |
| CAPEX | — | — | — | — | — | New“~2% of sales” | Reiterated“~2% of sales” | Reiterated“~2% of sales” |
| Corporate costs | — | — | — | — | — | New“~$170M” | Reiterated“~$170M” | Reiterated“~$170M” |
| Currency | — | — | — | — | — | — | New“~+0.5%” | Raised“~+1%” |
| Net interest expense | — | — | — | — | — | New“~$230M” | Reiterated“~$230M” | Reiterated“~$230M” |
| Organic growth | — | — | — | — | — | — | New“flat to 2%” | Widened“+1% to +3%” |
| Share count | — | — | — | — | — | New“~394M” | Reiterated“~394M” | Lowered“~391.5M” |
| For FY2025 | ||||||||
| Revenue - Industrial Technologies & Services (Organic) | — | New“1-3%” | Lowered“(1)-1%” | — | — | — | — | — |
| Revenue - Ingersoll Rand (Organic) | — | New“1-3%” | Lowered“(1)-1%” | — | — | — | — | — |
| Revenue - Precision & Science Technologies (Organic) | — | New“1-3%” | Lowered“(1)-1%” | — | — | — | — | — |
| Revenue - Total Ingersoll Rand | — | New“3-5%” | Reiterated“3-5%” | Raised“4-6%” | Reiterated“4-6%” | — | — | — |
| Total revenue growth (phasing) | — | New“3-5%” | — | — | — | — | — | — |
| Adjusted EBITDA | — | New“$2,130 to $2,190 million, up 6% to 9% over prior year” | Lowered“$2,070M - $2,130M (+3% - +6% YoY)” | Raised“$2,100M - $2,160M (+4% - +7% YoY)” | Lowered“$2,060M - $2,090M (+2% - +4% YoY)” | — | — | — |
| Adjusted EPS | — | New“$3.38 to $3.50, up 3% to 6% over prior year” | Lowered“$3.28 - $3.40 (~Flat - +3% YoY)” | Raised“$3.34 - $3.46 (+2 - +5% YoY)” | Changed“$3.25 - $3.31 ((1%) - +1% YoY)” | — | — | — |
| Corporate Costs | — | New“(~$165M)” | Reiterated“(~$165M)” | Lowered“(~$160M)” | Lowered“(~$140M)” | — | — | — |
| FX Impact | — | New“(~2%)” | Lowered“(~0.5%)” | Raised“~1%” | Reiterated“~1%” | — | — | — |
| Industrial Technologies & Services (Organic) | — | — | — | New“(2)-0%” | Reiterated“(2)-0%” | — | — | — |
| Ingersoll Rand (Organic) | — | — | — | New“(2)-0%” | Reiterated“(2)-0%” | — | — | — |
| Precision & Science Technologies (Organic) | — | — | — | New“(2)-0%” | Reiterated“(2)-0%” | — | — | — |
| Share repurchase target | — | — | New“up to $750 million of share repurchases” | — | — | — | — | — |
| For FY2024 | ||||||||
| Revenue - Industrial Technologies & Services (Organic) | New“(2)-0%” | — | — | — | — | — | — | — |
| Revenue - Ingersoll Rand (Organic) | New“(2)-0%” | — | — | — | — | — | — | — |
| Revenue - Precision & Science Technologies (Organic) | New“(2)-0%” | — | — | — | — | — | — | — |
| Revenue - Total Ingersoll Rand | New“5-7%” | — | — | — | — | — | — | — |
| Total revenue growth | — | New“3-5%” | — | — | — | — | — | — |
| Total revenue growth | — | New“3-5%” | — | — | — | — | — | — |
| Total revenue growth | New“5% to 7%” | — | — | — | — | — | — | — |
| Adjusted EBITDA | New“$2,010 to $2,040 million, up 12% to 14% over prior year” | — | — | — | — | — | — | — |
| Adjusted EPS | New“$3.28 to $3.34, up 11% to 13% over prior year” | — | — | — | — | — | — | — |
| Corporate Costs | New“(~$170M)” | — | — | — | — | — | — | — |
| FX Impact | New“~Flat” | — | — | — | — | — | — | — |
| No period stated | ||||||||
| Adjusted EBITDA | New“$2,010M - $2,040M (+12% - +14% YoY)” | Raised“$2,130M - $2,190M (+6% - +9%)” | — | — | — | — | — | — |
| Adjusted EPS | New“$3.28 - $3.34 (+11% - +13% YoY)” | Raised“$3.38 - $3.50 (+3% - +6%)” | — | — | — | — | — | — |
| Industrial Technologies & Services (Organic) | New“(2)-0%” | Raised“1-3%” | Lowered“(1)-1%” | — | — | — | — | — |
| Ingersoll Rand (Organic) | New“(2)-0%” | Raised“1-3%” | Lowered“(1)-1%” | — | — | — | — | — |
| Precision & Science Technologies (Organic) | New“(2)-0%” | Raised“1-3%” | Lowered“(1)-1%” | — | — | — | — | — |
| Share repurchase program authorization increase | — | — | New“$1 billion” | — | — | — | — | — |
Values in quotation marks are the company’s words. Change labels compare each statement with the same metric and target year in the previous release. HighGravityData does not judge whether guidance was met.